Table 4.
Variables | high fat & low fiber group (n = 22) | low fat & high fiber group (n = 22) | p values |
---|---|---|---|
E1 (nmol/24h) | 22.70 ± 7.49 | 20.64 ± 8.11 | 0.266* |
E2 (nmol/24h) | 13.78 ± 6.87 | 10.85 ± 5.06 | 0.123* |
E3 (nmol/24h) | 26.74 ± 11.48 | 19.42 ± 10.38 | 0.025* |
E3-3G (nmol/24h) | 41.50 ± 17.98 | 27.34 ± 14.00 | 0.002* |
2-OHE1(nmol/24h) | 47.54 ± 19.45 | 37.16 ± 19.13 | 0.161 |
4-OHE1 (nmol/24h) | 8.15 ± 2.02 | 8.75 ± 3.12 | 0.861* |
2-OHE2 (nmol/24h) | 12.61 ± 4.99 | 7.44 ± 3.93 | 0.004 |
16α-OHE1 (nmol/24h) | 8.61 ± 4.47 | 5.58 ± 3.64 | 0.055 |
2-OHE1/4-OHE1 (nmol/24h) | 5.87 ± 2.37 | 4.17 ± 1.78 | 0.045* |
2-OHE1/16α-OHE1 (nmol/24h) | 8.36 ± 8.68 | 10.16 ± 7.63 | 0.709* |
2-OHE1/E1 (nmol/24h) | 2.08 ± 1.12 | 1.69 ± 0.57 | 0.478* |
4-OHE1/E1 (nmol/24h) | 0.36 ± 0.17 | 0.45 ± 0.20 | 0.202* |
16α-OHE1/E1 (nmol/24h) | 0.37 ± 0.22 | 0.30 ± 0.24 | 0.295* |
E3/16α-OHE (nmol/24h)1 | 4.78 ± 4.53 | 5.09 ± 3.17 | 0.663* |
2-OHE (2-OHE1+ 2-OHE2; nmol/24h) | 60.16 ± 23.63 | 44.60 ± 22.00 | 0.078 |
16α-OHE (16α-OHE1+E3; nmol/24h) | 38.09 ± 13.34 | 27.07 ± 12.76 | 0.032 |
2-OHE/16-OHE (nmol/24h) | 1.74 ± 0.85 | 2.14 ± 1.45 | 0.993* |
2-MeO-E1 (nmol/24h) | 7.90 ± 2.91 | 7.26 ± 3.25 | 0.590 |
15α-OHE1 (nmol/24h) | 0.86 ± 0.59 | 0.70 ± 0.39 | 0.386 |
16β-OHE1 (nmol/24h) | 3.02 ± 1.43 | 1.98 ± 1.90 | 0.023* |
16-ketoE2 (nmol/24h) | 5.76 ± 2.43 | 3.96 ± 2.58 | 0.067 |
16-epiE3 (nmol/24h) | 6.40 ± 3.62 | 3.89 ± 2.18 | 0.033* |
17-epiE3 (nmol/24h) | 2.27 ± 1.53 | 1.48 ± 0.81 | 0.123* |
Total urinary estrogens (nmol/24h) | 174 ± 47 | 132 ± 38 | 0.013 |
Means ± SD.
Significant p ≤ 0.050.
p values obtained using log variables values.
Independent sample t-test.
E1 = estrone; E2 = estradiol; E3 = estriol; Total estrogens = E1+ E2 +E3; E3-3G = estriol-3-glucuronide; OHE1 = hydroxyestrone; OHE2 = hydroxyestradiol: OHE = hydroxylated estrogens, all urinary estrogens = total estrogens + all estrogens metabolites (except E3-3G).